A phase i dose-escalation study of msc1992371a, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies
Graux, Carlos ; Sonet, Anne ; Maertens, Johan ; Duyster, Justus ; Greiner, Jochen ; Chalandon, Yves ; Martinelli, Giovanni ; Hess, Dagmar ; Heim, Dominik ; Giles, Francis J. ... show 6 more
Graux, Carlos
Sonet, Anne
Maertens, Johan
Duyster, Justus
Greiner, Jochen
Chalandon, Yves
Martinelli, Giovanni
Hess, Dagmar
Heim, Dominik
Giles, Francis J.
Repository DOI
Publication Date
2013-09-01
Type
Article
Downloads
Citation
Graux, Carlos; Sonet, Anne; Maertens, Johan; Duyster, Justus; Greiner, Jochen; Chalandon, Yves; Martinelli, Giovanni; Hess, Dagmar; Heim, Dominik; Giles, Francis J. Kelly, Kevin R.; Gianella-Borradori, Athos; Longerey, Blandine; Asatiani, Ekaterine; Rejeb, Narmyn; Ottmann, Oliver G. (2013). A phase i dose-escalation study of msc1992371a, an oral inhibitor of aurora and other kinases, in advanced hematologic malignancies. Leukemia Research 37 (9), 1100-1106
Abstract
Funder
Publisher
Elsevier BV
Publisher DOI
10.1016/j.leukres.2013.04.025
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland